BRIEF-Clairmark Investments reports 14.8 pct stake in Eleven Biotherapeutics

* Clairmark Investments reports 14.8 pct stake in Eleven Biotherapeutics as of September 20, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.